Elaine Sanij Selected Research

Proteins (Proteins, Gene)

3/2024	Targeting the ribosome to treat multiple myeloma.
1/2016	Combination Therapy Targeting Ribosome Biogenesis and mRNA Translation Synergistically Extends Survival in MYC-Driven Lymphoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Elaine Sanij Research Topics

Disease

25	Neoplasms (Cancer) 03/2024 - 02/2011
4	Ovarian Neoplasms (Ovarian Cancer) 01/2021 - 01/2020
3	Prostatic Neoplasms (Prostate Cancer) 11/2022 - 01/2017
3	Hematologic Neoplasms (Hematological Malignancy) 11/2020 - 07/2012
3	Lymphoma (Lymphomas) 01/2019 - 07/2012
2	Melanoma (Melanoma, Malignant) 01/2019 - 01/2018
2	Breast Neoplasms (Breast Cancer) 01/2019 - 01/2017
2	Leukemia 01/2017 - 07/2012
2	Genomic Instability 02/2015 - 01/2014
1	Multiple Myeloma 03/2024
1	Stomach Neoplasms (Stomach Cancer) 01/2022
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 11/2021
1	DNA Repair-Deficiency Disorders (Chromosome Instability Syndromes) 01/2020
1	ATR-X syndrome 01/2018
1	Carcinoma (Carcinomatosis) 01/2018
1	Carcinogenesis 01/2018
1	Starvation 05/2017
1	Colorectal Neoplasms (Colorectal Cancer) 01/2014
1	Retinoblastoma (Glioblastoma, Retinal) 07/2003

Drug/Important Bio-Agent (IBA)

14	CX 5461IBA 03/2024 - 02/2011
10	RNA Polymerase I (Polymerase I, RNA)IBA 03/2024 - 02/2011
10	Ribosomal DNA (rDNA)IBA 01/2021 - 07/2012
5	Poly(ADP-ribose) Polymerase InhibitorsIBA 11/2022 - 01/2018
4	Ribosomal RNAIBA 01/2020 - 02/2011
3	Mechanistic Target of Rapamycin Complex 1IBA 01/2020 - 02/2011
2	Proteins (Proteins, Gene)FDA Link 03/2024 - 01/2016
2	Androgen Receptors (Androgen Receptor)IBA 11/2022 - 11/2021
2	Biomarkers (Surrogate Marker)IBA 11/2022 - 01/2020
2	DNA (Deoxyribonucleic Acid)IBA 11/2020 - 10/2017
2	ChromatinIBA 01/2020 - 01/2019
2	palbociclibIBA 01/2019 - 01/2018
2	HeterochromatinIBA 01/2018 - 01/2014
2	Histones (Histone)IBA 01/2018 - 02/2015
2	Transcription Factors (Transcription Factor)IBA 02/2015 - 01/2014
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 11/2022
1	CystathionineIBA 01/2022
1	talazoparibIBA 11/2021
1	Cyclin-Dependent Kinase 4IBA 01/2019
1	Antineoplastic Agents (Antineoplastics)IBA 01/2019
1	Estrogen ReceptorsIBA 01/2019
1	Protein-Arginine N-Methyltransferases (Methyltransferase, Protein Arginine)IBA 01/2019
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2018
1	rucaparibIBA 01/2018
1	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2017
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 10/2017
1	Antiviral Agents (Antivirals)IBA 10/2017
1	Amino Acids FDA Link 08/2016
1	Eukaryotic Initiation Factor-4EIBA 01/2016
1	Everolimus FDA Link 01/2016
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 01/2014
1	Calcibiotic Root Canal SealerIBA 01/2014
1	DNA-Directed RNA Polymerases (RNA Polymerase)IBA 02/2011
1	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 07/2003
1	Oncogene Proteins (Oncogene Protein)IBA 07/2003

Therapy/Procedure

11	Therapeutics 11/2022 - 11/2013
1	Precision Medicine 11/2022
1	Drug Therapy (Chemotherapy) 01/2017